Luliconazole is a topical antifungal drug newly developed in Japan. The present study compares the in vitro antifungal activity of luliconazole against clinically important dermatomycotic fungi with that of other representative antifungal drugs. The reference drugs chosen were five classes of nine topical agents, i.e., allylamine (terbinafine), thiocarbamate (liranaftate), benzylamine (butenafine), morpholine (amorolfine), and azole (ketoconazole, clotrimazole, neticonazole, miconazole and bifonazole). The minimum inhibitory concentrations (MIC) of luliconazole and the reference drugs against Trichophyton spp. (T. rubrum, T. mentagrophytes and T. tonsurans) and Candida albicans were measured by the standardized broth microdilution method. Luliconazole demonstrated greater potency against Trichophyton spp. (MIC range: 50.00012Á0.002 mg/ml) than the reference drugs, with T. rubrum being the most susceptible to it. Luliconazole was also highly active against Candida albicans (MIC range: 0.031Á0.13 mg/ml), proving to be more potent than terbinafine, liranaftate, butenafine, amorolfine, and bifonazole, but less than ketoconazole, clotrimazole, neticonazole, and miconazole. Further, the MIC of luliconazole against Malassezia restricta, an important pathogenic agent involved in seborrhoeic dermatitis, was very low (MIC range: 0.004Á0.016 mg/ml) suggesting action comparable to or stronger than that of ketoconazole. These results indicate a possible clinical role for luliconazole with its broad-spectrum antimycotic activity.
Japan for use as a topical antifungal agent [4, 5] and is presently available as 1% creams and solutions for the treatment of superficial infections such as dermatophytoses, candidiasis and pityriasis versicolor.
The in vitro activities of antifungal drugs constitute an important source of information for physicians seeking the most appropriate choice of topical antifungal remedies available for the treatment of superficial fungal infections. Although there is a wide variety of topical antifungal drugs already available in Japan that possess a broad spectra of potent antifungal activity, comparable data on the in vitro antifungal activity of these drugs are limited because measurements of the minimum inhibitory concentration (MIC) vary considerably with experimental conditions and testing facilities [6Á8] . In the present study, the MICs of luliconazole against the dermatomycotic pathogenic fungi Trichophyton spp. and Candida albicans, were directly compared with the MICs of representative topical antifungal drugs available in Japan, using standardized broth microdilution methods [9Á11] . The reference drugs chosen were five classes of nine topical antifungals including terbinafine hydrochloride (allylamine class), liranaftate (thiocalbamine class), butenafine hydrochloride (benzylamine class), amorolfine hydrochloride (morpholine class), and ketoconazole, clotrimazole, neticonazole hydrochloride, miconazole nitrate, and bifonazole (azole class).
The lipophilic yeast, Malassezia, is considered to be involved in seborrhoeic dermatitis [12Á14], as well as the causative organism in pityriasis versicolor. The clinical efficacy of antifungal drugs in the treatment of SD has buttressed this hypothesis [15Á19] , and has popularized the use of ketoconazole [18Á20] for the treatment of SD in Japan. Recently, the taxonomy of genus Malassezia was revised by molecular methods [21Á23], and Malassezia restricta was found to be the dominant species in the SD skin lesions [24, 25] . The MIC of luliconazole against M. restricta was also determined and comparing it to the data from the use of ketoconazole.
Materials and methods

Antifungal agents
Luliconazole (LLCZ, 99.7% purity), neticonazole hydrochloride (NCZ, 94.5% purity), butenafine hydrochloride (BTF, 100% purity), terbinafine hydrochloride (TBF, 94.5% purity) and amorolfine hydrochloride (AMO, 97.5% purity) were synthesized and purified at the Research Center at Nihon Nohyaku Co. Ltd. (Osaka, Japan). Miconazole nitrate (MCZ, 100% purity), bifonazole (BFZ, !99% purity), ketoconazole (KCZ, !99% purity) and clotrimazole (CTZ, 99.6% purity) were purchased from Sigma-Aldrich (MO, USA). Lilanaftate (LNF, 99.6% purity) was kindly provided by Pola Pharma Inc. (Tokyo, Japan). The drugs were dissolved in dimethyl sulfoxide (DMSO) at a concentration of 1,600ug/ml from which a series of two fold dilutions were then prepared. The final drug concentrations for studies with Trichophyton spp ranged from: 0.00012Á0.016 ug/ml for LLCZ; 0.00098Á0.25 mg/ml for TBF, LNF, BTF and AMO; 0.0078 to 1 mg/ mL for CTZ and NCZ; and 0.002Á4 mg/ml for BFZ, MCZ and KCZ. In the investigations with C. albicans, the range of antifungals was from: 0.016Á1 mg/ml for LLCZ; 0.002Á0.13 mg/ml for KCZ; 0.0039Á1 mg/ml for NCZ, CTZ and MCZ; 0.016Á16 mg/ml for AMO; 0.13Á 16 mg/ml for TBF and BFZ; and 2Á16 mg/ml for LNF and BTF. For M. restricta, the final concentrations of LLCZ and KCZ ranged from 0.002Á2 mg/ml. The solvent in the assay system was 1.0%.
Test organisms
The 10 stock cultures of T. rubrum, T. mentagrophytes and C. albicans were obtained from Teikyo University Institute of Medical Mycology (TIMM; Tokyo, Japan), NITE Biological Resource Center (NBRC; Chiba, Japan) and American Type Culture Collection (ATCC; Maryland, USA). Clinical isolates of T. tonsurans (10 isolates) and M. restricta (10 isolates) were collected at Teikyo University and Tokyo Medical University during 2003Á2006. Identification of T. tonsurans and M. restricta were based on DNA sequence of nuclear ribosomal internal transcribed spacer 1 regions [26, 27] . For M. restricta, catalasenegative reaction, one of the key identifying characters of this species, was also confirmed. The results of identification were compatible with morphologic features of the organisms grown on their preculture media. For quality control of the assay, T. mentagrophytes ATCC18748 (American Type Culture Collection, USA) and C. parapsilosis ATCC22019 were used as reference strains. 
Culture media
For Trichophyton spp. and Candida spp., Sabouraud dextrose agar (SDA;Difco, MD, USA) and RPMI1640 broth without NaHCO 3 or phenol red with L-glutamine (Sigma-Aldrich, MO, USA) buffered to a pH of 7.0 with 0.165M 3-[N-morpholino] propanesulfonic acid (MOPS; Wako Pure Chemical Industries, Osaka, Japan) were used for the preculturing and assay medium, respectively. For M. restricta preculturing modified Leeming and Notman agar (LNA) comprised of 10 g/l peptone (Difco, MD, USA), 10 g/l D-glucose (Sigma-Aldrich, MO, USA), 2 g/l yeast extract (Difco, MD, USA), 8 g/l bile salt (Oxoid, Ontario, Canada), 0.5 g/l glycerol monostearate (Tokyo Chemical Industries, Tokyo, Japan), 10 ml/l glycerol (Sigma-Aldrich, MO, USA), 5 ml/l Tween 60 (Tokyo Chemical Industries, Tokyo, Japan), 20 ml/l olive oil (Nacalai Tesque Inc, Kyoto, Japan) and 15 g/l agar (Wako Pure Chemical Industries, Osaka, Japan) was used. The assay medium was LNA without milk (LNA(-)) and contained 10 g/l peptone, 5 g/L D-glucose, 0.1 g/l yeast extract, 8 g/l bile salt, 0.5 g/l glycerol monostearate, 1 ml/l glycerol, 0.5 ml/l Tween 60, and 12 g/l agar.
Inoculum preparation
Trichophyton spp. were grown on SDA slant at 278C for 1Á3 weeks, sterile saline with 0.1% (v/v) Tween 80 was then added to the slants and conidia suspended by gently rubbing the colony with a loop. The suspension was filtrated through sterilized gauze to remove hyphal fragments. The number of conidia in the filtrate was counted using a Thoma hemacytometer and the concentration adjusted to 2.0 )10 6 conidia/mL with sterile saline containing 0.1% (v/v) Tween 80. The conidia suspension was diluted 10 times with RPMI1640 broth containing 20%(v/v) Alamar Blue (Wako Pure Chemical Industries Ltd., Osaka, Japan). Candida albicans and C. parapsilosis were grown on SDA plate at 358C for one day. Five colonies of ]1 mm in diameter were suspended in 5.0 ml of sterile saline and vortexed for 15 sec. Cell density of the suspension was adjusted to 0.5 McFarland with sterile saline using a spectrophotometer, which resulted in 1.2 )10 6 Á5.0 )10 6 cells/ml, as calibrated by Thoma hemacytometer. The cell suspension was diluted 20 times with RPMI1640 broth and further diluted 100 times with RPMI1640 containing 20% (v/v) Alamar Blue. M. restricta was grown on a modified LNA plate at 328C for 3Á10 days. Colonies were harvested and suspended in an appropriate volume of 0.1% (v/v) Tween 80 solution and vortexed. After the suspension was allowed to stand for about 30 min to remove the aggregated cell sediment, the fine suspension was collected and the cell concentration adjusted to 1 )10 8 cells/ml with sterile saline.
MIC measurement
The MICs of Trichophyton spp. and C. albicans were measured by standardized microdilution methods [9Á 11] with colorimetric endpoint determination [10, 28] . Each drug solution prepared in DMSO was diluted 50-fold with the assay medium and a 100 ml aliquot of it was dispensed into each well on a series of 96-well plates (Multi Well Plate; Sumitomo Bakelite Co. Ltd., Tokyo, Japan). The wells were inoculated with 100 ml of the test organism and incubated at 278C for up to 7 days for Trichophyton spp. and at 358C for up to 2 days for Candida spp. A growth control containing a drugfree basal medium and a negative control consisting of a drug-free basal medium without inoculation were prepared for each strain. The plates were visually observed daily to ascertain the point at which the color of the medium in the growth control wells changed to a definite pink or red. Optical density (OD) at 570 nm was measured by dual wavelengths read (OD at 595 nm served as reference) with a microplate reader (THERMOmax, Molecular Devices Corporation, CA, USA). Duplicate assays were performed and their average OD was calculated. The minimum concentration of the test drug needed to lower the OD to less than 20% of the comparative growth control was defined as the MIC. Quality control (QC) was ensured each time using a set of strains according to the recommendations outlined in the methods [10, 11] . MICs for M. restricta were measured by the agar dilution method [29] with a streak inoculation. Each drug solution prepared in DMSO was mixed with LNA(-) (1:100, 20 ml medium /9 cm plate) to provide agar plates containing serial drug concentrations. A growth control was prepared with a drug-free basal medium. One ml of each organism was inoculated on the agar plate in a 1.5 cm streak using a loop. The plates were incubated at 328C for up to 7 days and visually observed daily until colony formation in the growth control was apparent. The minimum concentration of the drugs needed to inhibit fungal growth completely was recorded as the MIC. The assay was performed in duplicate and the higher of the two MIC values was taken as the final.
MIC range, the geometric mean MIC (MIC GM ), and MICs at which 50% and 90% of the isolates were inhibited (MIC 50 and MIC 90 ) were recorded for each strain and species.
Results
The MICs of LLCZ and the reference drugs against 30 strains of Trichophyton spp. and 10 strains of C. albicans are indicated in Table 1 and Table 2 , respectively. The MIC range and the MIC GM of the tested agents are summarized in Fig. 2 in order to illustrate the antifungal spectrum of the drugs. LLCZ exhibited extremely strong activity against Trichophyton spp. (total 30 strains) in terms of the MICs ranges. The MIC GM of LLCZ against T. rubrum, T. mentagrophytes and T. tonsurans were the lowest among all of the tested drugs. Trichophyton rubrum was the most susceptible for LLCZ, in that one isolate had a low off-scale MIC ( 50.00012 mg/ml) and the MIC for the other nine isolates were at the same range of 0.00024 mg/ml. Although the MIC of LLCZ for C. albicans (MIC GM : 0.055 mg/ml) was 125 times higher than that for Trichophyton spp. (MIC GM : 0.00044 mg/ml), the antifungal activity of LLCZ against C. albicans was still high in comparison with the reference drugs. The MIC GM of LLCZ against C. albicans was lower than those of TBF, LNF, BTF, AMO, and BFZ, but higher than those of KCZ, CTZ, NCZ, and MCZ.
Among the reference drugs, TBF of the allylamine class, LNF of the thiocalbamine class and BTF of the benzylamine class showed potent activity against Trichophyton spp., but not against C. albicans. In contrast to TBF, LNF and BTF, azole compounds such as KCZ, CTZ, NCZ, MCZ and BFZ were more active against C. albicans. KCZ was the most potent against C. albicans in the azole class. For Trichophyton spp., these reference azoles also exhibited potent activity, however the MIC GM was apparently higher than that of TBF, LNF or BTF. The MIC GM of the AMO of the morpholine class for Trichophyton spp. and for C. albicans were almost equivalent to that of the reference azoles.
Because antifungal susceptibility testing for the genus Malassezia has not been standardized, we employed the agar dilution method [29] commonly used for this species. The MICs of LLCZ and KCZ against 10 strains of M. restricta are listed in Table 3 . The MIC range of LLCZ was almost comparable to that of KCZ, whereas the MIC GM , MIC 50 and MIC 90 of LLCZ were lower than those of KCZ.
Discussion
Dermatomycoses are by far the most common superficial fungal infection. An epidemiological survey of dermatomycoses conducted in Japan in 2002 [30] reported that 12.3% of outpatients who visited the dermatology clinic were suffering from dermatomycoses.
Trichophyton rubrum and T. mentagrophytes were the main causative agents of the dermatophytoses reported. Trichophyton rubrum was the dominant species in conditions like tinea pedis, tinea corporis, tinea cruris and tinea unguium [30, 31] . Trichophyton tonsuran, known as the main causative organism of tinea capitis and tinea corporis in Europe and America, was introduced into Japan by athletes in the past decade [32Á35]. Recent outbreaks of T. tonsurans-tinea capitis and tinea corporis among young athletes have become a major concern for physicians in Japan [36, 37] . Against these clinically important dermatophytes (T. rubrum, T. mentagrophytes and T. tonsurans), LLCZ exerted the strongest antifungal activity in comparison with the other five classes of drugs. T. rubrum was the most susceptible to LLCZ. A MIC GM was noted which was lower than that of TBF which is known as a strong anti-dermatophytes drug. The results reflect favorably on the clinical efficacy of 1% LLCZ cream for short-term (2 weeks) treatment of tinea pedis involving one application per day [4, 5] . Candidiasis caused by C. albicans is the second most common fungal skin infection in Japan after dermatophytoses. LLCZ showed potent activity against this organism as well. The MIC of LLCZ, was lower than that of TBF, BTF, LNF and BFZ, but higher than that of KCZ, NCZ, CTZ and MCZ. However, it was sufficient to provide a favorable clinical assessment of the efficacy of 1% LLCZ cream against candidiasis.
Ergosterol is essential to membrane integrity and cell growth in fungi. All of the drugs tested in the present study functioned as ergosterol inhibitors, although the inhibitory point in the biosynthesis pathway and the antifungal properties are different in each class [38] . The azole class that is potent against both Trichophyton spp. and C. albicans inhibits C14a-lanosterol demethylase in the ergosterol biosynthesis pathway. In contrast to the azole class, the allylamine (TBF), thiocarbamate (LNF) and benzylamine (BTF) classes, which inhibit squalene epoxidase, an early step in the pathway, showed stronger anti-dermatophyte action with lower MICs against Trichophyton spp., but less efficacy against C. albicans. On the other hand, the morpholine class (AMO), which inhibits both of C14-reductase and C7-C8 isomerase later stages in the pathway, showed the same range of MICs against both of Trichophyton spp., and C. albicans compared with the azole class. It is noteworthy that LLCZ, though an azole class agent, was extremely potent against dermatophytes while also effective against C. albicans. The MIC GM of LLCZ against T. rubrum, T. mentagrophytes, and T. tonsurans was the lowest among the 5 classes of drugs, while its MIC GM for C. albicans fell into the same range as that of the azole class. The typical antifungal property of LLCZ might be due to its unique chemical structure ( Fig. 1) augmented by the introduction of an imidazole moiety into a ketene dithioacetate structure [39] . The ketene dithioacetate structure is responsible for a variety of bioactivities, as attested by the fact that chemicals derived from this structure have been used to treat rice blast disease [40] and certain liver conditions in humans [41] and livestock [42] . Seborrhoeic dermatitis is a common and chronic inflammatory disorder occurring in areas of the skin rich in sebaceous glands, such as the eyebrows, eye-lids and the nose. Although the etiology of SD seems to involve multiple factors including the genetic, environmental and/or hormonal, the role of the lipophilic yeast, Malassezia, in its pathogenesis has been strongly corroborated by the efficacy of antifungal drugs against this disease [15Á19, 43] . As M. restricta has been considered a pathogenic factor of SD [24, 25] , susceptibility of M. restricta to LLCZ was compared with that of KCZ which is the only drug clinically available for SD treatment in Japan [18Á20]. The anti-Malassezia activity of LLCZ has been documented [29] and this compound has been used clinically to treat Malassezia infections, such as pityriasis versicolor. However, susceptibility of M. restricta in the new taxonomy of the species has not been determined. LLCZ showed activity comparable to or stronger than that of KCZ against M. restricta. These results underscore the utility of LLCZ for the management of SD.
In conclusion, LLCZ is a potent antifungal drug for dermatomycotic fungi. The in vitro antifungal potency of LLCZ, because of its extremely strong anti-dermatophytic properties, is different from those of other azoles. The MICs of LLCZ against T. rubrum, T. mentagrophytes, and T. tonsurans were lowest among the representative drugs clinically available in Japan. Furthermore, LLCZ demonstrates high in vitro potency against M. restricta, an important pathogenic factor in seborrheic dermatitis. These results underscore the clinical utility of luliconazole as a potent, broadspectrum antimycotic agent. 
